Mediterranean diet and Pilates study on obesity-linked ovarian blood flow moves to not yet recruiting — LiveFuture News
Open on LiveFuture.ai →

Mediterranean diet and Pilates study on obesity-linked ovarian blood flow moves to not yet recruiting

ClinicalTrials.gov lists a randomized Cairo University study comparing a Mediterranean diet alone with the same diet plus Pilates in obese females with polycystic ovarian syndrome.

A Cairo University study is listed as NOT_YET_RECRUITING, so anyone watching obesity-related research should know this is still at the registry stage. The trial compares a Mediterranean diet group with a Mediterranean diet and Pilates exercise group in obese females with polycystic ovarian syndrome.

As of 2026-11-13T00:00:00+00:00, ClinicalTrials.gov shows no posted results. The study title focuses on whether Pilates changes Doppler parameters, which are ultrasound measures that can reflect blood flow and resistance.

Registry observation: Effects of Pilates Exercises on Doppler Parameters in Obese Females With Polycystic Ovarian Syndrome (NA, NOT_YET_RECRUITING).

What the study is set up to test

The design is randomized, meaning participants are assigned to one of the two study arms rather than choosing a group themselves. One arm is labeled Mediterranean diet group, and the other is Mediterranean diet and Pilates exercise group.

The intervention list is simple: Mediterranean diet for both groups, with Pilates exercise added only in the experimental arm. That makes the exercise component the main difference the study appears set to examine.

The planned measurements are also broad. Over 8 weeks, the study will track body weight, body height, body mass index, and waist-hip ratio, alongside Peak systolic velocity (PSV), end-diastolic velocity (EDV), Resistance index (RI), and Pulsatility index (PI).

Why the readout matters

For a general reader, the practical takeaway is that the study is not trying to answer one narrow question. It is watching both body-size measures and blood-flow-related Doppler measures at the same time.

The registry description says PSV reflects the extent of vascular filling and blood supply, while EDV reflects the blood perfusion situation of the distal tissue. It also says lower values of RI and PI indicate higher blood flow.

Because the overall status is still NOT_YET_RECRUITING and the primary completion date is estimated at 2027-04-15, this is best read as a live research plan rather than a finished finding. The record itself says study outcomes require posted results.

This trial also fits the broader Obesity & Metabolic special event, where several related clinical-trial signals are centered on weight, metabolism, diet, exercise, and access to care.

Where it sits in the wider topic

The linked special event is Obesity & Metabolic, and this study belongs there by topic. It adds a diet-and-exercise angle to a field already tracking several obesity-related clinical trials.

For readers following the area, the useful detail is not a breakthrough result but a clear setup: a randomized comparison, an estimated timeline, and a defined set of ultrasound and body-composition measures.

That makes the study worth watching, but not yet summarizing as an outcome. For now, it is an early registry entry with a specific question and no posted results.

This record describes a study and its registry status; study outcomes require posted results.